Get startedLog in
    Picture of Terns Pharmaceuticals logo

    TERN — Terns Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapNeutral
    All News

    Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma

    Picture of Terns Pharmaceuticals logoTerns Pharmaceuticals
    25/03/2026 10:48
    March 25 (Reuters) - Merck MRK.N said on Wednesday it would buy biotech Terns Pharma TERN.O in a deal valued at up to $6.7 billion, as the drugmaker races to bolster its cancer pipeline ahead of the looming patent loss for its blockbuster therapy Keytruda.

 (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sriraj Kalluvila)

 ((siddhi.mahatole@thomsonreuters.com;))

    Recent news on Terns Pharmaceuticals

    See all news